This disclosure relates generally to the field of surgery. More particularly it relates to devices and methods to support weak tissue or for moving two regions of tissue towards each other to reconnect or support tissue that is separated or at risk of separation.
The written disclosure herein describes illustrative embodiments that are non-limiting and non-exhaustive. Reference is made to certain such illustrative embodiments that are depicted in the figures, in which:
Other features of the present embodiments will be apparent from the accompanying drawings and from the detailed description that follows.
Soft tissue injuries such as lacerations of ligaments and tendons can be repaired using sutures. However, when the tissue is under stress such as tensile stress, high tension can result at discrete suture sites and cause sutures to tear through the tissue. Torn tissue can require a repeat surgery to be repaired. The disclosed tissue repair devices can be used to effectively ligate and/or support torn or otherwise damaged tissue. The disclosed tissue repair devices distribute tension along repaired tissue and thus decrease the risk of injured tissue being torn after repair.
Soft tissue tears, such as tears of the Patellar and Achilles tendon rupture, can result in “mop ends” or frayed edges at the torn ends. These frayed ends can be time consuming and difficult to suture together, particularly in a manner to promote healing of the tear. The disclosed tissue repair devices can gather frayed mop ends and promote healing.
The disclosed tissue repair devices and methods can also be used to connect or support other elongate tissue within the body such as nerves and blood vessels. Sutures injure tissue in order to remain fixed in place. The disclosed tissue repair devices and methods of treatment can connect or support weak, damaged, or severed tissue while causing minimal or no damage to the tissue.
The present disclosure provides tissue repair devices for recombining, reconnecting and/or supporting torn, damaged or weak tissue. Specifically the disclosed devices can be used on elongate, slender tissue such as ligaments, tendons, nerves, vessels, intestines, muscles, bones, appendages and any other elongate tissue within the body. The devices can be used in both humans and animals. The present disclosure also provides methods for recombining, reconnecting or supporting torn, damaged or weak tissue, including administering the disclosed devices onto damaged tissue. The present disclosure also provides manufacturing processes for the creation of a device to reconnect damaged tissue.
The disclosed embodiments offer improved distribution of tension compared to sutures to prevent tissue from tearing under stress.
The disclosed embodiments do not need to pierce the tissue to remain in place.
The disclosed embodiments may reconnect or support tissue that is separated or at risk of separation.
In accordance with the principles of the present disclosure, the disclosed embodiments decrease tension at the wound site by distributing tension along the device and alleviating direct tension on the tissue.
The disclosed embodiments can encircle and engage or grip elongate tissue, using principles of friction and constriction, without causing damage to the tissue, for example, to support the damaged elongate tissue and/or to maintain two separated ends of the elongate tissue in close proximity to one another. The disclosed embodiments can provide mechanical support, stability, and the introduction of biologics such as proteins, cells, and growth factors to injured tissue. The disclosed embodiments may facilitate healing by allowing nutrients and oxygen to diffuse into the tissue through the gaps in the coils. For example, the disclosed embodiments may be porous, drug-eluting, and/or otherwise enhanced to promote tissue regeneration and cellular growth of the damaged tissue.
The disclosed embodiments may facilitate early mobilization of the injured tissue by stretching and moving with the tissue. The disclosed embodiments may reduce time to repair torn and injured tissue, compared to suturing and other methods. The disclosed embodiments may be used in conjunction with or in place of sutures.
The disclosed embodiments can be connected directly to soft tissue, and may not involve mounting to, for example bone, thus, limiting or even preventing any damage to the bone growth plate. The disclosed embodiments may enable tendons or ligaments that become frayed and swollen to be enclosed within a coil to more easily slide within the tight sheath. The disclosed embodiments may also facilitate manipulation of the severed tendon through the sheath during surgery.
One embodiment may be connected to soft tissue at a first end and bone at a second end to reduce tension at the soft tissue-bone interface.
The disclosed embodiments can encapsulate frayed mop ends of a ligament or tendon, thus reducing the need for complex suturing and decreasing risk of scar adhesion within the tissue sheath.
The disclosed embodiments can constrict upon a suture site so that the tendons can glide more readily within the sheath.
The disclosed embodiments may allow soft tissue to press up or outward between the coils, creating multiple catch points to inhibit or even prevent the tissue from slipping within the coil.
The disclosed embodiments may decrease in diameter upon extension, constricting on the elongate tissue and remaining in place even during extension. In particular, a lumen through the device may decrease in diameter upon extension. This decrease in diameter upon extension, can accommodate the decrease in diameter of elongate tissue that may occur when the elongate tissue is extended, thus allowing the device to maintain proper contact and engagement during extension and relaxation of the elongate tissue. The disclosed embodiments may employ principles of friction and constriction to remain in place and maintain contact with injured tissue.
The disclosed embodiments may increase in diameter during relaxed states, allowing for the least constriction and maximum diffusion of nutrients to the damaged tissue within the device.
The disclosed embodiments can be made of biodegradable polymers that can be broken down by the body after the injured tissue is sufficiently healed, allowing the native tissue to return to its normal state. Examples of polymers and constituents of co-polymers that can be used are polycaprolactone, polyurethane, polylactic acid, polyglycolic acid, polyvinyl alcohol, polyvinylpyrrolidone, polyester, and poly(hydroxyalkanoate).
The disclosed embodiments can be made of naturally biodegradeable materials that can be broken down by the body after the injured tissue is healed, allowing the native tissue to return to its normal state. Examples of natural materials that can be used are extracellular matrix proteins such as collagen, fibronectin, fibrinogen, lamanin, elastin, keratin and polysaccharides, such as starch, cellulose, and chitosan.
The disclosed embodiments can also be infused with, or otherwise include nutrients, supplements, medicaments, sugars, growth factors, proteins, and/or hormones, which may promote and enhance healing of the elongate tissue. For example, as the biodegredable polymers and/or natural materials may include elements to promote tissue growth and/or healing that may be released as the biodegradeable polymers and/or natural materials are broken down by the body.
The disclosed embodiments can be made of non-biodegradable polymers that will remain in place to continue to support the injured tissue. Examples of polymers and constituents of co-polymers that can be used are polytetrafluoroethylene, polyurethane, polystyrene, polycarbonate, polyester, polysulfone, polyethylene terephthalate, polyethylene, polypropylene, polyurethane, silicone, polydimethylsiloxane, polymethylmethacrylate, and polyhydroxyethyl methacrylate, and polyetheretherketone.
The disclosed embodiments can be made of metals or metal alloys that will remain in place to continue to support the injured tissue. Examples of metals or constituents of metal alloys that can be used include nitinol, stainless steel, cobalt, chromium, titanium, platinum, iridium, tungsten, tantalum, aluminum, vanadium, molybdenum, silver, copper, silicon, and tin.
The disclosed embodiments can be made of metals or metal alloys that can degrade. Examples of metals or components in metal alloys that can be used include iron, magnesium, silicon, cobalt, tungsten, boron, carbon, lead, and sulfur.
The disclosed embodiments can be made of a ceramic that can be degradable or non-degradable. Examples of ceramics include hydroxyapetite, bioglass, calcium phosphate, titanium nitride, tungsten carbide, titanium carbon nitride, aluminas, SiO2, Na2O, CaO, P2O5 and zirconia.
The disclosed embodiments may include deployment during surgery by positioning the open end of the coil at one of the ends onto the tissue and twisting the coil onto the tissue much like twisting a key ring onto a key.
The disclosed embodiments may involve twisting the coil onto the ligament or tendon, which may allow the device to be deployed at a site of a partial tear and complete tear of the injured elongate tissue.
The disclosed embodiments may include deployment during surgery by suturing each end of the severed tissue and using the sutures to pull the tissue into the lumen of the coiled device.
The disclosed embodiments may include deployment by reversing the coil of the device to increase the diameter of the coil to more easily allow insertion of wounded tissue.
The presently disclosed embodiments of devices may be created using injection molding processes.
The presently disclosed embodiments of devices can be created by wrapping extruded polymer around a dowel.
The presently disclosed embodiments of devices can be created by wrapping metal around a dowel.
Certain embodiments of the present disclosure will now be discussed with reference to the accompanying drawings and reference numerals provided therein so as to enable one skilled in the art to practice the present invention. The drawings and descriptions are examples of various aspects of the invention and are not intended to narrow the scope of the claims to the inventions. Also, for the sake of simplicity, the illustrated devices and tissue may be represented as cylindrical in shape, however each of these embodiments can be altered to accommodate a device and tissue shape that is not cylindrical.
The coil member 103 may be formed of a biodegradable polymers and/or natural materials that can be broken down by the body after the injured tissue is sufficiently healed, allowing the native tissue to return to its normal state. Examples of polymers and constituents of co-polymers that can be used are polycaprolactone, polyurethane, polylactic acid, polyglycolic acid, polyvinyl alcohol, polyvinylpyrrolidone, polyester, and poly(hydroxyalkanoate). Examples of natural materials that can be used are extracellular matrix proteins such as collagen, fibronectin, fibrinogen, lamanin, elastin, keratin and polysaccharides, such as starch, cellulose, and chitosan.
The coil member 103 can be infused with, or otherwise include nutrients, supplements, medicaments, sugars, growth factors, proteins, and/or hormones, which may promote and enhance healing of the elongate tissue. For example, as the biodegredable polymers and/or natural materials may include elements to promote tissue growth and/or healing that may be released as the biodegradeable polymers and/or natural materials are broken down by the body.
Portions (or all) of the coil member 103 may be porous. The porosity of the coil member 103 may promote tissue growth and/or cellular in-growth, which may enhance engagement or securement of the tissue repair device 100 relative to the injured tissue and/or surrounding tissue. Porosity of the coil member may also contribute to coil compliance and degradation rate. As will be described below, coating may be employed to enhance or reduce porosity of the coil member 103.
In one embodiment, the coatings described above may be porous. A porous surface of the coiled member may promote cellular in-growth, which may further stabilize and ensure fixation of the tissue repair device relative to surrounding tissue. In another embodiment, the coiled member 1100 itself may be porous and the coating may reduce porosity where cellular in-growth may not be desired.
As described above, a coil member 1303 of the tissue repair device 1300 may be formed of a biodegradable polymers and/or natural materials that can be broken down by the body after the injured tissue is sufficiently healed, allowing the native tissue to return to its normal state. The coil member 1303 can be infused with, or otherwise include nutrients, supplements, medicaments, sugars, growth factors, proteins, and/or hormones, which may promote and enhance healing of the elongate tissue. For example, as the biodegredable polymers and/or natural materials may include elements to promote tissue growth and/or healing that may be released as the biodegradeable polymers and/or natural materials are broken down by the body. Eventually the entire coil member 1303 may break down and/or be absorbed by the body, as shown in
Additional embodiments include any suitable combination of the features depicted in the drawings. Accordingly, although a specific permutation may not be illustrated as a stand-alone embodiment in any of the drawings, all of the features are shown and described in the drawings such that the present drawings provide full support for these additional embodiments.
The disclosed embodiments may comprise a device with a center shape that can accommodate the shape of the tissue to be ligated or supported. These shapes include but are not limited to: circle, elliptical, square, rectangle, triangle trapezoid, or any combination of these shapes that may change shape along the length of the device. For example one end can begin as a circle cross section, but end as an ellipsoid cross section.
The disclosed embodiments may use the number and tightness of coils to control the grip onto the tissue
The disclosed embodiments may use principles of friction and constriction to maintain contact with tissue.
The disclosed embodiments may comprise a coil member used to make a coil that can have various shaped cross-sectional areas including circle, elliptical, square, rectangle, triangle trapezoid, etc., or any combination of these shapes and where these shapes can change along the length of the coil member.
The disclosed embodiments may comprise a coil member that can be made of varying thicknesses of material that can vary along the length of the device.
The disclosed embodiments where the device comprises an elongate hollow coiled member of biocompatible, surgically implantable material. The member having a first and second end, with the device being open at both ends.
The disclosed embodiments may comprise a method for treating weakened, damaged, and partially or completely lacerated tissue, wherein this method comprises obtaining a tissue repair device and accessing injured tissue within the body.
One of the disclosed embodiments may be a method of manufacturing a tissue repair device, comprising: preparing a biocompatible material; forming the biocompatible material into a coil comprising a series of interconnected turns defining a lumen through the coil, the lumen being open at both ends and configured to receive and encircle an elongate tissue to be repaired, wherein the material in a hardened state is configured to allow the coil to be extendable to increase a distance between adjacent turns of the plurality of turns and increase a length of the coil and to decrease a diameter of one or more of the turns of the plurality of turns proportional to extension of the length to more tightly engage an elongate tissue disposed within the lumen to decrease tension at a wound site of the elongate tissue by distributing tension along a length of the coil; and allowing the biocompatible material to set.
The method of manufacture may further include texturing an inner surface of the coil to enhance engagement of the inner surface with tissue to be repaired and limit sliding of the tissue repair device relative to the tissue to be repaired.
The examples and embodiments disclosed herein are to be construed as merely illustrative and exemplary, and not a limitation of the scope of the present disclosure in any way. It will be understood to those having skill in the art that changes may be made to the details of the above-described embodiments without departing from the underlying principles of the disclosure herein. For example, any suitable combination of various embodiments, or the features thereof, is contemplated. For example, any of the devices disclosed herein can include features of other embodiments. The scope of the invention is therefore defined by the following claims and their equivalents.
The present application is a divisional application of U.S. patent application Ser. No. 13/796,607, filed, Mar. 12, 2013, and entitled “TISSUE REPAIR DEVICES AND METHODS” which claims benefit of priority under 35 U.S.C. § 119(e) of U.S. Provisional Patent Application No. 61/736,000, filed Dec. 11, 2012, and entitled “RECOMBINATION AND SUPPORT DEVICES AND METHODS FOR INJURED TISSUE”, both of which are hereby incorporated herein by refence in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
4204541 | Kapitanov | May 1980 | A |
4300244 | Bokros | Nov 1981 | A |
4512338 | Balko et al. | Apr 1985 | A |
4881939 | Newman | Nov 1989 | A |
5191903 | Donohue | Mar 1993 | A |
5556428 | Shah | Sep 1996 | A |
5583319 | Lieurance | Dec 1996 | A |
5972001 | Yoon | Oct 1999 | A |
5984896 | Boyd et al. | Nov 1999 | A |
6063111 | Hieshima et al. | May 2000 | A |
6171320 | Monassevitch | Jan 2001 | B1 |
6171338 | Talja et al. | Jan 2001 | B1 |
6174333 | Kadiyala et al. | Jan 2001 | B1 |
6485503 | Jacobs | Nov 2002 | B2 |
6648911 | Sirhan | Nov 2003 | B1 |
6984241 | Lubbers | Jan 2006 | B2 |
7344558 | Lorenzo | Mar 2008 | B2 |
7611521 | Lubbers | Nov 2009 | B2 |
8556930 | Ellingwood | Oct 2013 | B2 |
8833130 | Matsunaga | Sep 2014 | B2 |
9427309 | Kubiak | Aug 2016 | B2 |
11123177 | Valavanis | Sep 2021 | B2 |
20010044637 | Jacobs | Nov 2001 | A1 |
20020010481 | Jayaraman | Jan 2002 | A1 |
20030040790 | Furst | Feb 2003 | A1 |
20030040803 | Rioux et al. | Feb 2003 | A1 |
20030114920 | Caro et al. | Jun 2003 | A1 |
20030195562 | Collier et al. | Oct 2003 | A1 |
20040193217 | Lubbers | Sep 2004 | A1 |
20040260384 | Allen | Dec 2004 | A1 |
20060095058 | Sivan et al. | May 2006 | A1 |
20060142845 | Molaei et al. | Jun 2006 | A1 |
20060212047 | Abbott et al. | Sep 2006 | A1 |
20070056591 | McSwain | Mar 2007 | A1 |
20070203519 | Lorenzo et al. | Aug 2007 | A1 |
20080004640 | Ellingwood | Jan 2008 | A1 |
20080228146 | Shaked et al. | Sep 2008 | A1 |
20090132031 | Cook et al. | May 2009 | A1 |
20090142132 | Klein | Jun 2009 | A1 |
20090157168 | Degen | Jun 2009 | A1 |
20090248142 | Perkins et al. | Oct 2009 | A1 |
20100010293 | Sato et al. | Jan 2010 | A1 |
20100010514 | Ishioka | Jan 2010 | A1 |
20100010520 | Takahashi et al. | Jan 2010 | A1 |
20100168841 | Furst et al. | Jul 2010 | A1 |
20100292785 | Seguin et al. | Nov 2010 | A1 |
20110276071 | Connor et al. | Nov 2011 | A1 |
20120083820 | Carman et al. | Apr 2012 | A1 |
20120215236 | Matsunaga | Aug 2012 | A1 |
20120226296 | Bindra et al. | Sep 2012 | A1 |
20130013065 | Bills | Jan 2013 | A1 |
20130103166 | Butler et al. | Apr 2013 | A1 |
20140163586 | Holt | Jun 2014 | A1 |
20220054133 | Holt | Feb 2022 | A1 |
Number | Date | Country |
---|---|---|
2832319 | Feb 2015 | EP |
2004073221 | Mar 2004 | JP |
2009039139 | Feb 2009 | JP |
2002039906 | May 2002 | WO |
2006072926 | Jul 2006 | WO |
2011091169 | Jul 2011 | WO |
Entry |
---|
European Search Report dated Jul. 12, 2016 for EP application 13863287. |
Core Essence Orthopedics, Inc. , “Pontis Endotendonous Repair System”, 2011 Core Essence Orthopedics, Inc. |
Diraimo Jr. , et al., “Distal Biceps Tendon Repair Using the Toggle Loc with Zip Loop”, Orthopedics, Dec. 2008, vol. 31, No. 12, pp. 1201-1204. |
Su , et al., “Device for Zone-II Flexor Tendon Repari”, The Journal of Bone and Joint Surgery, JBJS.Org, vol. 87-A, No. 5, May 2005. |
Tantadprasert , et al., “A Biomechanical Comparison of a Tendon Repair Device and 4 Stranded, Cruciate Repair Sutures for Flexor Tendon Ruptured”, J Med Assoc Thai vol. 92, No. 11, 2009. |
Number | Date | Country | |
---|---|---|---|
20220054133 A1 | Feb 2022 | US |
Number | Date | Country | |
---|---|---|---|
61736000 | Dec 2012 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13796607 | Mar 2013 | US |
Child | 17465464 | US |